Subscribe to RSS
Download PDF
DOI: 10.1055/s-2002-26709
© Georg Thieme Verlag Stuttgart · New York
General Screening for Celiac Disease is Advisable in Children with Type 1 Diabetes
Publication History
29 October 2001
16 January 2002
Publication Date:
30 April 2002 (online)
Abstract
The association between celiac disease (CD) and diabetes mellitus type 1 is well known. Only about one-third of all patients with CD are diagnosed in childhood as a result of typical gastrointestinal symptoms or growth retardation. To evaluate the feasibility of CD screening in diabetic children, we tested autoantibodies to tissue transglutaminase (tTGA) in all children with type 1 diabetes from our pediatric department during a 12-month period. In antibody-positive cases, we analyzed the clinical presentation and offered a duodenal biopsy to confirm the diagnosis and grade the severity of the inflammatory process. Of 205 children, 13 (6.3 %) were tTGA-positive. In seven of eight children who agreed to perform a biopsy, CD typical histological signs were detected (Marsh 1: n = 1, Marsh 3: n = 6). In three patients with confirmed disease, symptoms (iron deficiency, recurrent abdominal pain) remained undiscovered up to time of screening (latent form); in four, the disease was asymptomatic (silent form). Since clinical symptoms are mostly mild or absent in spite of severe signs of duodenal inflammation, we recommend tTGA screening in all diabetic children. This strategy may allow the identification of patients in an early stage in respect of prevention of long-term complications.
Key words
Tissue Transglutaminase Antibodies - Diabetes Mellitus - Gluten
References
- 1 Johnston S D, Watson R G, McMillan S A, Sloan J, Love A H. Prevalence of coeliac disease in Northern Ireland. Lancet.. 1997; 350 (9088) 1370
- 2 Pruessner H T. Detecting celiac disease in your patients. Am Fam Physician.. 1998; 57 1034-1041
- 3 Boudraa G, Hachelaf W, Benbouabdellah M, Belkadi M, Benmansour F Z, Touhami M. Prevalence of coeliac disease in diabetic children and their first-degree relatives in west Algeria: screening with serological markers. Acta Paediatr Suppl.. 1996; 412 58-60
- 4 Freemann H J. Survey of gastroenterologists on the diagnosis and treatment of adult patients with celiac disease in British Columbia. Can J Gastroenterol.. 1998; 12 149-152
- 5 Madriano Cobo O, Lorenzo Hernandez A, Fernandez Capitan C, Arnalich Fernandez F, Vazquez Rodriguez J J. Coeliac disease in the adult. An Med Interna. 1998; 15 (6) 327-333
- 6 Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken E O, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med.. 1997; 3 (7) 797-801
- 7 Molberg O, Mc Adam S N, Sollid L M. Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr. 2000; 30 232-240
- 8 Kordonouri O, Dieterich W, Schuppan D, Webert G, Muller C, Sarioglu N, Becker M, Danne T. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med. 2000; 17 (6) 441-444
- 9 Lagerqvist C, Ivarsson A, Juto P, Persson L A, Hernell O. Screening for adult coeliac disease - which serological marker(s) to use ?. J Intern Med. 2001; 250 (3) 241-248
- 10 Seissler J, Boms S, Wohlrab U, Morgenthaler N G, Mothes T, Boehm B O, Scherbaum W A. Antibodies to human recombinant tissue transglutaminase: Evidence for a high diagnostic sensitivity for coeliac disease. Horm Metab Res. 1999; 31 (6) 375-379
- 11 Marsh M. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology. 1992; 102 330-354
- 12 Prader A, Largo R H, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age: First Zuerich longitudinal study of growth and development. Helv Paediatr Acta. 1988; 51 Suppl 1-125
- 13 Hoffenberg E J, Bao F, Eisenbarth G S, Uhlhorn C, Haas J E, Sokol R J, Rewers M. Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr. 2000; 137 (3) 356-360
- 14 Hallert C, Lohiniemi S. Quality of life of celiac patients living on a gluten-free diet. Nutrition. 1999; 15 (10) 795-797
- 15 Fabiani E, Taccari L M, Ratsch I M, di Giuseppe S, Coppa G V, Catassi C. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr. 2000; 136 (6) 841-843
- 16 Iafusco D, Rea F, Chiarelle F, Mohn A, Prisco F. Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes care. 2000; 23 (5) 712-713
- 17 Barera G, Mora S, Brambilla P, Ricotti A, Menni L, Beccio S, Bianchi C. Body composition in children with celiac disease and the effects of a gluten-free diet: a prospective case-control study. Am J Clin Nutr. 2000; 72 (1) 71-75
- 18 Semrad C E. Bone mass and gastrointestinal disease. Ann N Y Acad Sci. 2000; 904 564-570
- 19 Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology. 1999; 117 297-303
- 20 Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut. 2001; 49 (4) 502-505
- 21 Ferguson A, Kingstone K. Coeliac disease and malignancies. Acta Paediatr Suppl. 1996; 412 78-81
- 22 Corrao G, Corazza G R, Bagnardi V, Brusco G, Ciacci C, Cottone M, Guidetti C S, Usai P, Cesari P, Pelli M A, Loperfido S, Volta U, Calabro A, Certo M. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001; 358 (9279) 356-361
- 23 Foss H D, Stein H. Pathology of intestinal lymphomas. Rec Res Cancer Res. 2000; 156 33-41
- 24 Patey-Mariaud D e, Cellier C, Jabri B, Delabesse E, Verkarre V, Roche B, Lavergne A, Briere J, Mauvieux L, Leborgne M, Barbier J P, Modigliani R, Matuchansky C, MacIntyre E, Cerf-Bensussan N, Brousse N. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 2000; 37 (1) 70-77
- 25 Gale J, Simmonds P D, Mead G M, Sweetenham J W, Wright D H. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000; 18 795
- 26 Carbonnel F, Grollet-Bioul L, Brouet J C, Teilhac M F, Cosnes J, Angonin R, Deschaseaux M, Chatelet F P, Gendre J P, Sigaux F. Are complicated forms of celiac disease cryptic T-cell lymphomas?. Blood. 1998; 92 (10) 3879-3886
U. Spiekerkoetter
Vanderbilt University · D-2220 Medical Center North
1161 21st Ave. South · Nashville, 37232 Tennessee · USA
Email: ute.spiekerkoetter@mcmail.vanderbilt.edu ·
Fax: +1 (615) 322 22 10
Phone: +1 (615) 322 26 35